Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
JsW35Qmjj6rAewur
